Bioscience

Biozona Weekly: UA veterinary program; Ebola treatment; Concussion research

August 29, 2014

By Flinn Foundation

Growing downtown tech biz has a record for hiring UA grads
8/27/14 | KVOA | Lauren Reimer

Sinfonia Health Care and its newest spin-off, SinfoniaRX, a medical call center, make one of the fastest growing technology based health companies in the country–and it started at the University of Arizona.

Commerce Authority, Tech Council unveil innovation award finalists
8/27/14 | Phoenix Business Journal | Hayley Ringle

The Arizona Technology Council and Arizona Commerce Authority named the winners and finalists for the 11th annual Governor’s Celebration of Innovation awards that honor the state’s technology industry visionaries.

ASU football teams up with Riddell for concussion research

8/26/14 | KTAR | Staff Report

The Arizona State University football team will be a big part of concussion treatment and research for the second year in a row by once again teaming up with Translational Genomics Research Institute and Riddell.

UA researcher Barnes provides insights into aging, memory
8/25/14 | Arizona Daily Star | Tom Beal

Carol Barnes, a psychologist and neuroscientist who heads the University of Arizona’s Evelyn F. McKnight Brain Institute, offers some thoughts on aging in a recent interview.

AHCCCS concerned about Banner/UA Health merger

8/24/14 | Arizona Daily Star | Stephanie Innes

Officials with Arizona’s Medicaid program, or Arizona Health Care Cost Containment System (AHCCCS), have concerns about Banner Health’s planned merger with the University of Arizona Health Network and aim to preserve the integrity of the bidding process that results in AHCCCS contracts.

UA veterinary program aims to start up in 2015
8/22/14 | Arizona Daily Star | Tom Beal

The University of Arizona will use a $9 million donation from the Kemper and Ethel Marley Foundation to establish a veterinary medical school with plans to enroll its first class in 2015.
 
ASU researchers encouraged by Ebola virus patients recovery
8/21/14 | CBS5 | Jason Barry

A research team at Arizona State University that helped develop the experimental treatment that was used on the two Americans infected with the deadly Ebola virus are feeling good about their work, even though it’s unknown what impact the experimental drug ZMapp had on their recovery.

UA program to help firms win research funding
8/21/14 | Arizona Daily Star | David Wichner

The University of Arizona has launched an initiative to help small tech startups win critical federal research funding in an effort to boost the region’s economic competitiveness.

Paradigm, Forma Therapeutics Partner to ID Molecular Markers for Preclinical Candidates
8/12/14 | GenomeWeb | Staff Report

Paradigm, a spinout of International Genomics Consortium, and Forma Therapeutics have announced a multiyear partnership to identify predictive response biomarkers and measure pharmacodynamic activity for two of Forma’s advanced preclinical candidates.